A systematic review of combination step III opioid therapy in cancer pain: An EPCRC opioid guideline project

Palliative Medicine

Volumn 25, Issue 5, 2011, Pages 597-603

  Fallon, Marie T ^a   Laird, Barry Ja ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Neoplasm; opioid combination; opioids; pain

Indexed keywords

FENTANYL; METHADONE; MORPHINE; OPIATE; OXYCODONE;

ANALGESIA; ANALGESIC ACTIVITY; CANCER PAIN; CHRONIC PAIN; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HUMAN; NAUSEA AND VOMITING; PRACTICE GUIDELINE; SUSTAINED DRUG RELEASE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANALGESICS, OPIOID; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; EUROPE; HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT; PRACTICE GUIDELINES AS TOPIC;

EID: 79959879348     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216310392101     Document Type: Conference Paper

References (30)

1. Martin WR. History and development of mixed opioid agonists, partial agonists and antagonists. Br J Clin Pharmacol. 1979 ; 7 (Suppl 3). 273S - 279S (Pubitemid 9244529)
2. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 1999 ; 82: 263-274
3. Mercadante S. Opioid rotation for cancer pain: rationale and clinical aspects. Cancer. 1999 ; 86: 1856-1866 (Pubitemid 29513057)
4. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004: CD004847.
5. Narabayashi M, Saijo Y, Takenoshita S, et al. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial. Jpn J Clin Oncol. 2008 ; 38: 296-304 (Pubitemid 351583994)
6. Azevedo Sao Leao Ferreira K, Kimura M, Jacobsen Teixeira M. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it?. Support Care Cancer. 2006 ; 14: 1086-1093 (Pubitemid 44898790)
7. Snyder SH. Opiate receptors and beyond: 30 years of neural signaling research. Neuropharmacology. 2004 ; 47 (Suppl 1). 274-285 (Pubitemid 39298270)
8. Rogers JF, Nafziger AN, Bertino JS. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs. Am J Med. 2002 ; 113: 746-750 (Pubitemid 36044701)
9. Benitez-Rosario MA, Salinas-Martin A, Aguirre-Jaime A, Perez-Mendez L, Feria M. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors. J Pain Symptom Manage. 2009 ; 37: 1061-1068
10. Mercadante S, Porzio G, Ferrera P, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain. 2008 ; 12: 1040-1046
11. Mercadante S, Villari P, Ferrera P, Casuccio A, Mangione S, Intravaia G. Transmucosal fentanyl vs. intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. Br J Cancer. 2007 ; 96: 1828-1833 (Pubitemid 46912022)
12. Clark AJ, Ahmedzai SH, Allan LG, et al. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin. 2004 ; 20: 1419-1428 (Pubitemid 39361345)
13. Coluzzi PH, Schwartzberg L, Conroy JD, et al. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain. 2001 ; 91: 123-130 (Pubitemid 32274181)
14. Heiskanen T, Kalso E. Controlled-release oxycodone and morphine in cancer-related pain. Pain. 1997 ; 73: 37-45 (Pubitemid 27470824)
15. Shinjo T, Okada M. [The opioid combination of transdermal fentanyl and sustained-release morphine for refractory cancer pain-a case report]. Gan To Kagaku Ryoho. 2005 ; 32: 1997-2000
16. Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer. 2003 ; 89: 2027-2030 (Pubitemid 38030898)
17. Mercadante S, Villari P, Ferrera P, Casuccio A. Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer. 2004 ; 12: 762-766 (Pubitemid 40064258)
18. Mercadante S. Opioid combination for cancer pain. Br J Cancer. 2004 ; 90: 2049-2049
19. Mercadante S, Portenoy RK. Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manage. 2001 ; 21: 338-354 (Pubitemid 32331888)
20. Fallon M, Colvin L. Opioid-induced hyperalgesia: fact or fiction?. Palliat Med. 2008 ; 22: 5-6 (Pubitemid 351351365)
21. Colvin LA, Fallon MT. Opioid-induced hyperalgesia: a clinical challenge. Br J Anaesth. 2009 ; 104: 125-127
22. Smith MT. Differences between and combinations of opioids re-visited. Curr Opin Anaesthesiol. 2008 ; 21: 596-601
23. Pasternak GW. Incomplete cross-tolerance and multiple mu opioid peptide receptors. Trends Pharmacol Sci. 2001 ; 22: 67-70 (Pubitemid 32149274)
24. Ross FB, Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain. 1997 ; 73: 151-157 (Pubitemid 27491675)
25. Ross FB, Wallis SC, Smith MT. Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side effects in rats. Pain. 2000 ; 84: 421-428 (Pubitemid 30074246)
26. Virk MS, Williams JT. Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization. Mol Pharmacol. 2008 ; 73: 1301-1308 (Pubitemid 351439212)
27. Staahl C, Dimcevski G, Andersen SD, et al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol. 2007 ; 42: 383-390
28. Grach M, Massalha W, Pud D, Adler R, Eisenberg E. Can coadministration of oxycodone and morphine produce analgesic synergy in humans? An experimental cold pain study. Br J Clin Pharmacol. 2004 ; 58: 235-242 (Pubitemid 39209056)
29. Smith MT and de la Iglesia FA. Co-administration of oxycodone and morphine and analgesic synergy re-examined. Br J Clin Pharmacol 2005; 59: 486-487; author reply 7-8.
30. Blumenthal S, Min K, Marquardt M, Borgeat A. Postoperative intravenous morphine consumption, pain scores, and side effects with perioperative oral controlled-release oxycodone after lumbar discectomy. Anesth Analg. 2007 ; 105: 233-237 (Pubitemid 46975870)